# Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome

> **NCT05737030** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Medical University of Graz** · enrollment: 55 (estimated)

## Conditions studied

- Cirrhosis

## Interventions

- **DRUG:** L-ornithine L-aspartate

## Key facts

- **NCT ID:** NCT05737030
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-06
- **Primary completion:** 2024-07-23
- **Final completion:** 2025-12
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05737030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05737030, "Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05737030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*